New cancer clinical trial: Computed Tomography Perfusion Imaging in Predicting Outcomes in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Receiving Bevacizumab

Published on: January 26, 2018 at 12:00PM
Conditions:   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Intervention:   Radiation: Computed Tomography Perfusion Imaging
Sponsors:   ECOG-ACRIN Cancer Research Group;   National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2rM6rOt